Completed
Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma
NCT00107718
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Santa Monica, California, United States
- GSK Investigational Site New Haven, Connecticut, United States